[1] |
aumgartner RN, Koehler KM, Gallagher D, et al. Epidemiology of sarcopenia among the elderly in new Mexico[J]. Am J Epidemiol, 1998, 147(8):755-763.
doi: 10.1093/oxfordjournals.aje.a009520
pmid: 9554417
|
[2] |
Kim G, Kang SH, Kim MY, et al. Prognostic value of sarco-penia in patients with liver cirrhosis:a systematic review and meta-analysis[J]. PLoS One, 2017, 12(10):e0186990.
doi: 10.1371/journal.pone.0186990
|
[3] |
Tantai XX, Liu Y, Yeo YH, et al. Effect of sarcopenia on survival in patients with cirrhosis:a meta-analysis[J]. J Hepatol, 2022, 76(3):588-599.
doi: 10.1016/j.jhep.2021.11.006
|
[4] |
Van Vugt J, Buettner S, Alferink L, et al. SUN-P072:low skele-tal muscle mass is associated with increased hospital costs in patients with cirrhosis listed for liver transplantation[J]. Clin Nutr, 2017, 36:S80.
|
[5] |
伍静薇, 张莉, 杨平. 肝硬化伴肌少症病人运动干预研究进展[J]. 护理研究, 2020, 34(23):4221-4225.
|
|
Wu JW, Zhang L, Yang P. Research progress of exercise intervention in patients with liver cirrhosis and sarcopenia[J]. Chin Nurs Res, 2020, 34(23):4221-4225.
|
[6] |
Dicenso A, Bayley L, Haynes RB. Accessing pre-appraised evi-dence:fine-tuning the 5S model into a 6S model[J]. Evid Based Nurs, 2009, 12(4):99-101.
doi: 10.1136/ebn.12.4.99-b
pmid: 19779069
|
[7] |
Brouwers MC, Kerkvliet K, Spithoff K, et al. The AGREE Repor-ting Checklist:a tool to improve reporting of clinical practice guidelines[J]. BMJ, 2016, 352:i1152.
|
[8] |
陈尹, 胡世莲, 李幼平, 等. 全球药物干预治疗单纯性高血压指南的系统评价[J]. 中国循证医学杂志, 2012, 12(10):1180-1194.
|
[9] |
顾莺, 张慧文, 周英凤, 等. JBI循证卫生保健中心关于不同类型研究的质量评价工具:系统评价的方法学质量评价[J]. 护士进修杂志, 2018, 33(8):701-703.
|
[10] |
顾莺, 张慧文, 周英凤, 等. JBI循证卫生保健中心关于不同类型研究的质量评价工具:分析性研究的质量评价[J]. 护士进修杂志, 2018, 33(5):400-403.
|
[11] |
王春青, 胡雁. JBI证据预分级及证据推荐级别系统(2014版)[J]. 护士进修杂志, 2015, 30(11):964-967.
|
[12] |
Lai JC, Tandon P, Bernal W, et al. Malnutrition,frailty,and sarcopenia in patients with cirrhosis:2021 practice guidance by the American association for the study of liver diseases[J]. Hepatology, 2021, 74(3):1611-1644.
doi: 10.1002/hep.32049
|
[13] |
Yoshiji H, Nagoshi S, Akahane T, et al. Evidence-based clini-cal practice guidelines for Liver Cirrhosis 2020[J]. J Gas-troenterol, 2021, 56(7):593-619.
|
[14] |
Carey EJ, Lai JC, Sonnenday C, et al. A North American expert opinion statement on sarcopenia in liver transplantation[J]. Hepatology, 2019, 70(5):1816-1829.
doi: 10.1002/hep.30828
pmid: 31220351
|
[15] |
Kamada Y, Takahashi H, Shimizu M, et al. Clinical practice advice on lifestyle modification in the management of nonalcoholic fatty liver disease in Japan:an expert review[J]. J Gastroenterol, 2021, 56(12):1045-1061.
doi: 10.1007/s00535-021-01833-9
|
[16] |
Aamann L, Dam G, Rinnov A, et al. Physical exercise for people with cirrhosis[J]. Cochrane Database Syst Rev, 2018, 12(12):CD012678.
|
[17] |
Naseer M, Turse EP, Syed A, et al. Interventions to improve sarcopenia in cirrhosis:a systematic review[J]. World J Clin Cases, 2019, 7(2):156-170.
doi: 10.12998/wjcc.v7.i2.156
|
[18] |
Brustia R, Savier E, Scatton O. Physical exercise in cirrhotic pa-tients:towards prehabilitation on waiting list for liver trans-plantation. A systematic review and meta-analysis[J]. Clin Res Hepatol Gastroenterol, 2018, 42(3):205-215.
doi: 10.1016/j.clinre.2017.09.005
|
[19] |
Gonzalez A, Valero-Breton M, Huerta-Salgado C, et al. Impact of exercise training on the sarcopenia criteria in non-alcoholic fatty liver disease:a systematic review and meta-analysis[J]. Eur J Transl Myol, 2021, 31(1):9630.
|
[20] |
Johnston HE, Takefala TG, Kelly JT, et al. The effect of diet and exercise interventions on body composition in liver cirrhosis:a systematic review[J]. Nutrients, 2022, 14(16):3365.
doi: 10.3390/nu14163365
|
[21] |
Jamali T, Raasikh T, Bustamante G, et al. Outcomes of exer-cise interventions in patients with advanced liver disease:a systematic review of randomized clinical trials[J]. Am J Gas-troenterol, 2022, 117(10):1614-1620.
|
[22] |
Duarte-Rojo A, Ruiz-Margáin A, Montaño-Loza AJ, et al. Exer-cise and physical activity for patients with end-stage liver disease:improving functional status and sarcopenia while on the transplant waiting list[J]. Liver Transpl, 2018, 24(1):122-139.
doi: 10.1002/lt.24958
|
[23] |
Faustini Pereira JL, Galant LH, Rossi D, et al. Functional ca-pacity,respiratory muscle strength,and oxygen consumption predict mortality in patients with cirrhosis[J]. Can J Gastroe-nterol Hepatol, 2016, 2016:6940374.
|
[24] |
Hallsworth K, Fattakhova G, Hollingsworth KG, et al. Resista-nce exercise reduces liver fat and its mediators in non-alcoholic fatty liver disease independent of weight loss[J]. Gut, 2011, 60(9):1278-1283.
doi: 10.1136/gut.2011.242073
pmid: 21708823
|
[25] |
Francaux M, Deldicque L. Exercise and the control of muscle mass in human[J]. Pflugers Arch, 2019, 471(3):397-411.
doi: 10.1007/s00424-018-2217-x
|
[26] |
Hashida R, Kawaguchi T, Bekki M, et al. Aerobic vs. resistance exercise in non-alcoholic fatty liver disease:a systematic review[J]. J Hepatol, 2017, 66(1):142-152.
doi: S0168-8278(16)30488-3
pmid: 27639843
|
[27] |
Whitsett M, VanWagner LB. Physical activity as a treatment of non-alcoholic fatty liver disease:a systematic review[J]. World J Hepatol, 2015, 7(16):2041-2052.
doi: 10.4254/wjh.v7.i16.2041
pmid: 26261693
|
[28] |
Iwanaga S, Hashida R, Takano Y, et al. Hybrid training system improves insulin resistance in patients with nonalcoholic fatty liver disease:a randomized controlled pilot study[J]. Tohoku J Exp Med, 2020, 252(1):23-32.
doi: 10.1620/tjem.252.23
pmid: 32863329
|